RAC 3.33% $1.55 race oncology ltd

Cardioprotection thread, page-690

  1. 6,692 Posts.
    lightbulb Created with Sketch. 841
    yes only trials in mice to date and need to move into trials with humans…. These are the things happening around the cardio protection chemo world at the moment

    The cost of treatment for Doxo will be increased how many times by adding a $20k a pop dose compared to the relatively cheap doxorubicin - FDA already approved drug if trials go well will have a quick pathway to market
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.